Xuemei Wu

1.9k total citations · 1 hit paper
58 papers, 1.3k citations indexed

About

Xuemei Wu is a scholar working on Molecular Biology, Public Health, Environmental and Occupational Health and Epidemiology. According to data from OpenAlex, Xuemei Wu has authored 58 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 13 papers in Public Health, Environmental and Occupational Health and 12 papers in Epidemiology. Recurrent topics in Xuemei Wu's work include Reproductive Biology and Fertility (10 papers), Pharmacovigilance and Adverse Drug Reactions (7 papers) and Pneumocystis jirovecii pneumonia detection and treatment (6 papers). Xuemei Wu is often cited by papers focused on Reproductive Biology and Fertility (10 papers), Pharmacovigilance and Adverse Drug Reactions (7 papers) and Pneumocystis jirovecii pneumonia detection and treatment (6 papers). Xuemei Wu collaborates with scholars based in China, United States and Hong Kong. Xuemei Wu's co-authors include Martin M. Matzuk, John J. Eppig, Maria M. Viveiros, Susan L. Fitzpatrick, Yuchen Bai, You‐Qiang Su, Frank L. Pendola, Marilyn J. O’Brien, Christopher Brown and Carol Hanna and has published in prestigious journals such as Nature Genetics, Antimicrobial Agents and Chemotherapy and Developmental Biology.

In The Last Decade

Xuemei Wu

56 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Exploration of the potential association between GLP-1 receptor agonists and suicidal or self-injurious behaviors: a pharmacovigilance study based on the FDA Adverse Event Reporting System database

2024 51 citations Jianxing Zhou, Maobai Liu et al. profile →

Peers

Countries citing papers authored by Xuemei Wu

Since Specialization

Citations

This map shows the geographic impact of Xuemei Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuemei Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuemei Wu more than expected).

Fields of papers citing papers by Xuemei Wu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xuemei Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuemei Wu. The network helps show where Xuemei Wu may publish in the future.

Co-authorship network of co-authors of Xuemei Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Xuemei Wu. A scholar is included among the top collaborators of Xuemei Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xuemei Wu. Xuemei Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The safety profile of usage of glucagon‐like peptide‐1 receptor agonists in pregnancy: A pharmacovigilance analysis based on the Food and Drug Administration Adverse Event Reporting System 2024 ·British Journal of Clinical Pharmacology ·Jianxing Zhou, (unknown), (unknown), Maobai Liu, Xuemei Wu	3
2	Multiple Adverse Reactions Associated With the Use of Second-Generation Antipsychotics in People With Alzheimer’s Disease: A Pharmacovigilance Analysis Based on the FDA Adverse Event Reporting System 2024 ·Annals of Pharmacotherapy ·Jianxing Zhou, (unknown), Wei Huang, Maobai Liu, Xuemei Wu	1
3	Population Pharmacokinetic Modeling Using Polymyxin B Free Plasma Concentrations From Published Reports and Evaluation of Dosage Regimens Based on Monte Carlo Simulation in Critically Ill Patients 2023 ·The Journal of Clinical Pharmacology ·(unknown), (unknown), Shengyang Chen, Maobai Liu, (unknown), Jingting Wang, Xuemei Wu	5
4	Disproportionality Analysis of Lenvatinib‐Caused Gastrointestinal Perforation in Cancer Patients: A Pharmacovigilance Analysis Based on the US Food and Drug Administration Adverse Event Reporting System 2023 ·The Journal of Clinical Pharmacology ·Jianxing Zhou, (unknown), (unknown), (unknown), (unknown), (unknown), Jialin Huang, Xuemei Wu	4
5	Movement disorders associated with antiseizure medications: A real‐world disproportionality analysis of the Food and Drug Administration Adverse Event Reporting System 2023 ·British Journal of Clinical Pharmacology ·Jianxing Zhou, (unknown), Shengyang Chen, (unknown), Wei Huang, Maobai Liu, Xuemei Wu	8
6	Saliva as a noninvasive sampling matrix for therapeutic drug monitoring of intravenous busulfan in Chinese patients undergoing hematopoietic stem cell transplantation: A prospective population pharmacokinetic and simulation study 2023 ·CPT Pharmacometrics & Systems Pharmacology ·(unknown), Ting Yang, Jianxing Zhou, (unknown), Jingting Wang, Qingxia Liu, Dandan Li, Yifan Zhang, Maobai Liu, Xuemei Wu	1
7	O‐GlcNAcylation Regulates Centrosome Behavior and Cell Polarity to Reduce Pulmonary Fibrosis and Maintain the Epithelial Phenotype 2023 ·Advanced Science ·Yu Fan, Song Yang, Hua Ni, (unknown), Xuemei Wu, (unknown), (unknown), Yuxin Cao, (unknown), Di An, Dengwen Li, Dayong Liu, Lin Liu, Leiting Pan, Quan Chen, Xueliang Zhu, Jun Zhou	10
8	External Evaluation of Population Pharmacokinetic Models for High‐Dose Methotrexate in Adult Patients with Hematological Tumors 2023 ·The Journal of Clinical Pharmacology ·Shengyang Chen, (unknown), (unknown), (unknown), Li Shen, Maobai Liu, Wansheng Chen, Xuemei Wu	3
9	Behavioral adaptation in an adoptive free-ranging female Tibetan macaque 2023 ·Primates ·Xuemei Wu, Jie Zhang, (unknown), Binghua Sun, Dong‐Po Xia	2
10	Pharmacovigilance of triazole antifungal agents: Analysis of the FDA adverse event reporting system (FAERS) database 2022 ·Frontiers in Pharmacology ·Jianxing Zhou, (unknown), (unknown), Maobai Liu, (unknown), Xuemei Wu	17
11	Effect of posaconazole on the concentration of intravenous and oral cyclosporine in patients undergoing hematopoietic stem cell transplantation 2022 ·European Journal of Clinical Pharmacology ·(unknown), (unknown), (unknown), Yan Wang, (unknown), (unknown), Xuemei Wu	4
12	External evaluation of population pharmacokinetic models for voriconazole in Chinese adult patients with hematological malignancy 2022 ·European Journal of Clinical Pharmacology ·(unknown), (unknown), (unknown), (unknown), Maobai Liu, (unknown), Xuemei Wu	7
13	Can Published Population Pharmacokinetic Models of Busulfan Be Used for Individualized Dosing in Chinese Pediatric Patients Undergoing Hematopoietic Stem Cell Transplantation? An External Evaluation 2021 ·The Journal of Clinical Pharmacology ·(unknown), Maobai Liu, (unknown), Jianda Hu, (unknown), Dandan Li, (unknown), Shaozhen Chen, (unknown), Xuemei Wu	1
14	The specialized mitotic behavior of human embryonic stem cells 2021 ·Cell and Tissue Research ·(unknown), Xuemei Wu, Nan Ma, Difei Wang, Shuang Sun, (unknown), Jun Zhou, Xinyi Lu, Min Liu, Dengwen Li	3
15	An evaluation of statistical models for age estimation and the assessment of the 18-year threshold using conventional pelvic radiographs 2020 ·Forensic Science International ·Fei Fan, (unknown), Xuemei Wu, (unknown), Xinhua Dai, Kui Zhang, Feijun Huang, Zhenhua Deng	9
16	Functional Polymorphisms in hOGG1 Gene and Neuroblastoma Risk in Chinese Children 2018 ·Journal of Cancer ·Yizhen Wang, Zhenjian Zhuo, Yuan Fang, Lin Li, Jiao Zhang, Jing He, Xuemei Wu	4
17	Association of genetic variations in miR-146a rs2910164 and miR-149 rs11614913 with the development of classic Kaposi sarcoma 2016 ·Genetics and Molecular Research ·Hsin‐Yi Yang, Qi Long Lu, Xuemei Wu, (unknown), Yanchun Qu, (unknown), Xingxiang Pu	4
18	Oxidative damage induces MCP-1 secretion and macrophage aggregation in age-related macular degeneration (AMD) 2016 ·Graefe s Archive for Clinical and Experimental Ophthalmology ·(unknown), Xuemei Wu, (unknown), Peng Li, Li Wang	28
19	WEE2 Is an Oocyte-Specific Meiosis Inhibitor in Rhesus Macaque Monkeys1 2010 ·Biology of Reproduction ·Carol Hanna, Shan Yao, Maristela Carbol Patta, Jeffrey T. Jensen, Xuemei Wu	42
20	Expression of insulin-like 3 (INSL3) and differential splicing of its receptor in the ovary of rhesus macaques 2010 ·Reproductive Biology and Endocrinology ·Carol Hanna, Shan Yao, Maristela Carbol Patta, Jeffrey T. Jensen, Xuemei Wu	22

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact